.avif)
Sage Therapeutics Email Format
Biotechnology Research
・
201-500 employees
・
Cambridge, MA, USA
Sage Therapeutics is a biopharmaceutical company developing novel therapies for debilitating brain disorders, pioneering new pathways to transform how neurological conditions are treated.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@sagerx.com
Company Overview
Industry
Biotechnology Research
Founded
2010
Headquarters
Cambridge, MA, USA
Revenue
$25M-$50M
FUNDING Stage
Public
Website
Key Executives
Barry Greene (Chief Executive Officer), Christopher Benecchi (Chief Operating Officer)
Tech Stack
Salesforce Marketing Cloud Personalisation
Marketing
Signup
to know
Signup
to know
Signup
to know
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Sage Therapeutics?
Sage Therapeutics uses the first.last format on sagerx.com, so Jane Smith would be jane.smith@sagerx.com.
What FDA-approved product does Sage Therapeutics currently market for postpartum depression?
Sage Therapeutics co-developed and commercializes ZURZUVAE (zuranolone) with Biogen, which became the first FDA-approved oral treatment for adults with postpartum depression in August 2023 and has been commercially available in the U.S. since December 2023.
Which neurodegenerative indications is Sage Therapeutics targeting with its dalzanemdor pipeline program?
Sage Therapeutics is studying dalzanemdor (SAGE-718), a first-in-class oral NMDA receptor positive allosteric modulator, in clinical trials for cognitive impairment associated with Huntington's disease and Alzheimer's disease.
How can I find and verify a Sage Therapeutics employee contact for outreach?
With around 205 employees at Sage Therapeutics, the team is relatively focused. Tools like Clay can help you identify the right contact, confirm their first.last@sagerx.com address, and build a targeted list before reaching out.
Where is Sage Therapeutics headquartered and who leads the company?
Sage Therapeutics is headquartered in Cambridge, MA, and is led by Barry Greene as Chief Executive Officer, with Christopher Benecchi serving as Chief Operating Officer.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating